AFTER A COUPLE OF DECADES, NEW CRITERIA TO DEFINE ALZHEIMER’S DISEASE HAVE ARRIVED, ELIZABETH TRACEY REPORTS
New criteria to diagnose Alzheimer’s disease have been released, indicating that the condition likely is discernable much earlier than anyone outside of the experts knew, but what are the practical implications? Constantine Lyketsos, an Alzheimer’s expert at Johns Hopkins, responds.
LYKETSOS: This is going to really accelerate and improve our ability to do the research to find the cures we’re looking for. Because we’re going to target our therapies much more specifically to people who have the specific disease that we’re after. Right now if we want to treat someone with MCI or dementia we’re not 100% sure in life that they have Alzheimer’s disease. These criteria are going to bring us much closer, so that if we’re developing a drug for amyloid, we are going to be enrolling in clinical trials people who really have a lot of amyloid in their brain, which we will know based on these biological tests as derived by these criteria. :35
At Johns Hopkins, I’m Elizabeth Tracey.